A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies

Summary

This clinical trial is designed to assess the safety, preliminary efficacy, and pharmacokinetics (PK) of DS3790a monotherapy and combination regimens in participants with hematological malignancies.

Timeline

Start

2026-01-16

Primary completion

2030-11-30

Completion

2030-11-30

Drugs

Indications